Berko İlaç Digitizes Its Quality Management Process

Berko Pharma Transitions Quality Management to Digital Platform Berko Pharma, which has transitioned its quality management processes from manual to digital, continues to grow in sync with modern business practices. By fully migrating quality management processes to the digital realm and adopting the Qmex software validated according to 21 CFR Part 11 requirements, Berko Pharma once again underscores its commitment to innovation and uncompromised quality. For over thirty-five years, Berko Pharma has worked and produced for public health under the motto "Healthy Tomorrows." The company has now implemented an innovation in quality management processes. By fully transitioning quality management processes to digital, Berko Pharma has demonstrated its innovative vision and commitment to quality through the Qmex software, validated according to 21 CFR Part 11 requirements, which enables all employees to easily access information. With Qmex, the intended benefits include electronic signature, module-based authorization, audit trail, record history, action-based scheduled notifications, personal dashboard, pending tasks, delegated tasks, bookmarks, charts and reporting, trend report tracking, multiple file attachment, related records screen, inter-module integration, integration with all third-party software including ERPs, powerful workflow management, and corporate reputation enhancement. By transitioning to the Qmex software system, Berko Pharma will be able to easily access all information from a single platform. Quality Assurance Manager Dr. Haluk Akkuş commented on the matter: "We have crowned our innovative and forward-looking vision by migrating our business processes to Qmex. We are pleased to take our place as part of the digital age in the business management processes we use at our company."